PTC Therapeutics outperformed the S&P 500 this year, according to data from August 8, 2025.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
PTC Therapeutics outperformed the S&P 500 this year, according to data from August 8, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
PTC Therapeutics
pharmaceutical company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- ZacksPTC Therapeutics (PTCT) Reports Q2 Loss, Beats Revenue Estimates PTC Therapeutics (PTCT) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $1.07. This